Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

Tianjin Medical University General Hospital: Clinical Trials & FDA Approval Profile

Tianjin Medical University General Hospital (Global / Institutional) sponsors 21 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 13 active protocols (5 recruiting now), 2 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)9.5%
Median Closed Enrollment vs National (145 pts)110 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Tianjin Medical University General Hospital
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)21
Active Pipeline (Recruiting Now)13 (5)
Completed vs Stopped Early2 / 2 (9.5%)
Median Closed Actual Enrollment110 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Tianjin Medical University General Hospital
Hospital Research SiteLocationShared Protocols
Tianjin Medical University General HospitalTianjin, Tianjin Municipality15

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Tianjin Medical University General Hospital
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT06452537Safety and Efficacy of Tocilizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-associated DiseasePhase II/IIIACTIVE NOT RECRUITING

Explore interactive annual charts and M&A subsidiary rollups in the Tianjin Medical University General Hospital Interactive Dossier, benchmark peers in Rare Genetic, Women's Health, and Other, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI